Roll-to-Roll Nanoscale Polymer Microsheets for Wound Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing molecularly thin polymeric sheets for wound healing and bacterial prevention are limited to small-scale batch production, which are inefficient and slow, and do not support large-scale manufacturing of microsheets with significant surface areas.
Innovation Solution
A process for large-scale manufacture of nanoscale microsheets involving a flexible substrate with a low surface energy surface, a nanoscale polymer layer, and a bioactive agent, using methods like roll-to-roll coating to produce flexible sheets with a surface area greater than 0.52 square meters, incorporating alternating layers of positively and negatively charged polyelectrolytes, and optionally a sacrificial or non-sacrificial second polymer layer to control bioactive agent release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If batch production methods are used to produce molecularly thin polymeric sheets, then the sheets can be manufactured with controlled thickness and bioactive agent incorporation, but the production scale is limited and manufacturing efficiency is low
Solution Approach 1:
The production process is segmented into distinct functional layers: a substrate layer, a molecularly thin polymeric sheet layer containing bioactive agents, and optional sacrificial or non-sacrificial polymer layers. This segmentation enables continuous manufacturing while maintaining precise control over each layer's properties, resolving the contradiction between productivity and manufacturing complexity.
Solution Approach 2:
The substrate is prepared in advance with specific surface properties (low surface energy, controlled roughness) to facilitate subsequent deposition of the polymeric sheet. Bioactive agents are pre-incorporated into the polymer matrix before sheet formation. These preliminary actions enable efficient continuous production while ensuring consistent product quality, addressing both productivity and ease of manufacture.
2Area of stationary object
If small-scale batch production is used, then manufacturing complexity is reduced, but the surface area of produced microsheets is limited
Solution Approach 1:
Multiple functional requirements are merged into a single integrated structure: the polymeric sheet simultaneously provides wound healing benefits, bacterial prevention, and controlled drug delivery. The substrate and polymeric sheet are combined into a unified composite structure that can be manufactured in large areas through continuous processes, resolving the contradiction between surface area and productivity.
3Productivity
If nanoscale polymer layers are deposited on large surface areas, then large-scale manufacturing is enabled, but control over bioactive agent release becomes more challenging
Solution Approach 1:
The polymeric sheet is designed with spatially varying properties: different regions or layers contain different concentrations of bioactive agents, different polymer compositions, or different release kinetics. This local quality variation enables precise control over drug release profiles across the entire large-area sheet, resolving the contradiction between manufacturing scale and release control precision.
Solution Approach 2:
The structure employs composite materials combining the substrate, polymeric sheet, and optional sacrificial or non-sacrificial layers. Each material component contributes specific properties: the substrate provides mechanical support and surface control, the polymeric sheet provides bioactive agent delivery, and the sacrificial layer enables controlled release. This composite approach enables large-scale manufacturing while maintaining precise release control through material composition rather than complex process control.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables efficient production of large-area nanoscale microsheets with controlled bioactive agent release, suitable for wound healing and bacterial prevention, enhancing wound healing processes and providing sustained delivery of therapeutic agents.
Implementation Method 1
the polymer multilayer comprises alternating layers of at least one positively charged polyelectrolyte and at least one negatively charged polyelectrolyte
Data Source
AI summary
The present invention relates to large scale manufacture of nanoscale microsheets for use in applications such as wound healing or modification of a biological or medical surface.